Karen Fehn

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

Stephen Peeke, Nishi Shah, Jennat Mustafa et al. · Journal of Hematology & Oncology · 2020 · 210 citations · Full text

Medicine, Hematology, Oncology +9

Phase I and Pharmacokinetic Study of the Ribonucleotide Reductase Inhibitor, 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, Administered by 96-Hour Intravenous Continuous Infusion

Scott Wadler, Della Makower, Caroline Clairmont et al. · Journal of Clinical Oncology · 2004 · 146 citations

Medicine, Pharmacokinetics, Pharmacology +17

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Yifan Tu, Dawn L. Hershman, Kapil N. Bhalla et al. · Breast Cancer Research and Treatment · 2014 · 61 citations

Medicine, Oncology, Pharmacology +13

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

Hyunah Yoon, Rachel Bartash, Inessa Gendlina et al. · JCI Insight · 2021 · 46 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC

Hyunah Yoon, Rachel Bartash, Inessa Gendlina et al. · medRxiv · 2020 · 23 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12